Pantoprazole Decreases Cell Viability and Function of Human Osteoclasts In Vitro
Proton pump inhibitors (PPIs) are commonly prescribed drugs that decrease stomach acidity and are thus often used to treat gastroesophageal reflux disease and as a preventative agent for the adverse effects of nonsteroidal anti-inflammatory drugs on the stomach mucosa. In recently published literatu...
Saved in:
Main Authors: | Markus Prause (Author), Claudine Seeliger (Author), Marina Unger (Author), Elizabeth Rosado Balmayor (Author), Martijn van Griensven (Author), Alexander Tobias Haug (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Osteogenic Effect and Cell Signaling Activation of Extremely Low-Frequency Pulsed Electromagnetic Fields in Adipose-Derived Mesenchymal Stromal Cells
by: Patrina S. P. Poh, et al.
Published: (2018) -
Pantoprazole (PPZ) Inhibits RANKL-Induced Osteoclast Formation and Function In Vitro and Prevents Lipopolysaccharide- (LPS-) Induced Inflammatory Calvarial Bone Loss In Vivo
by: Yu-Xi Li, et al.
Published: (2020) -
Pantoprazole Sodium Loaded Microballoons for the Systemic Approach: In Vitro and In Vivo Evaluation
by: Pravin Gupta, et al.
Published: (2017) -
Formulation and in-vitro evaluation of pantoprazole loaded pH-sensitive polymeric nanoparticles
by: Ahmed Mohammed Nasef, et al.
Published: (2017) -
Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole
by: Dolores Ochoa, et al.
Published: (2020)